Researchers identified antiretina antibodies in cancer patients with vision loss, targeting a specific 23,000-dalton CAR antigen. This discovery could aid in early detection of cancer-associated retinopathy (CAR) syndrome.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: